Characterizing dupilumab facial redness: A multi-institution retrospective medical record review
- 19 June 2019
- journal article
- letter
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 82 (1), 230-232
- https://doi.org/10.1016/j.jaad.2019.06.026
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Learning About Dupilumab-Associated ConjunctivitisJAMA Dermatology, 2019
- The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapyJAAD Case Reports, 2018
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisThe New England Journal of Medicine, 2016